Literature DB >> 18998739

Neurotrophic factors in neurodegenerative disorders : potential for therapy.

Fabio Fumagalli1, Raffaella Molteni, Francesca Calabrese, Paola Francesca Maj, Giorgio Racagni, Marco Andrea Riva.   

Abstract

Finding an effective therapy to treat chronic neurodegenerative disorders still represents an unmet and elusive goal, mainly because so many pathogenic variables come into play in these diseases. Recent emphasis has been placed on the role of neurotrophic factors in the aetiology of such disorders because of their role in the survival of different cell phenotypes under various adverse conditions, including neurodegeneration.This review summarizes the current status and the efforts to treat neurodegenerative disorders by the exogenous administration of neurotrophic factors in an attempt to replenish trophic supply, the paucity of which may contribute to the development of the illness. Although promising results have been seen in animal models, this approach still meets disparate and often insurmountable problems in clinical settings, presumably related to the unique nature of the human being.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18998739     DOI: 10.2165/0023210-200822120-00004

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  174 in total

1.  Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from excitotoxic damage.

Authors:  E Pérez-Navarro; E Arenas; J Reiriz; N Calvo; J Alberch
Journal:  Neuroscience       Date:  1996-11       Impact factor: 3.590

2.  Growth factor treatment of demyelinating disease: at last, a leap into the light.

Authors:  Richard M Ransohoff; Charles L Howe; Moses Rodriguez
Journal:  Trends Immunol       Date:  2002-11       Impact factor: 16.687

3.  Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using a lentiviral vector.

Authors:  Biljana Georgievska; Deniz Kirik; Carl Rosenblad; Cecilia Lundberg; Anders Björklund
Journal:  Neuroreport       Date:  2002-01-21       Impact factor: 1.837

4.  Striatopallidal neurons are selectively protected by neurturin in an excitotoxic model of Huntington's disease.

Authors:  Sònia Marco; Esther Pérez-Navarro; Eduard Tolosa; Ernest Arenas; Jordi Alberch
Journal:  J Neurobiol       Date:  2002-03

5.  Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease.

Authors:  M Narisawa-Saito; K Wakabayashi; S Tsuji; H Takahashi; H Nawa
Journal:  Neuroreport       Date:  1996-11-25       Impact factor: 1.837

6.  Enhanced survival, reinnervation, and functional recovery of intrastriatal dopamine grafts co-transplanted with Schwann cells overexpressing high molecular weight FGF-2 isoforms.

Authors:  Marco Timmer; Frauke Müller-Ostermeyer; Verena Kloth; Christian Winkler; Claudia Grothe; Guido Nikkhah
Journal:  Exp Neurol       Date:  2004-05       Impact factor: 5.330

7.  Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo.

Authors:  Päivi Lindholm; Merja H Voutilainen; Juha Laurén; Johan Peränen; Veli-Matti Leppänen; Jaan-Olle Andressoo; Maria Lindahl; Sanna Janhunen; Nisse Kalkkinen; Tõnis Timmusk; Raimo K Tuominen; Mart Saarma
Journal:  Nature       Date:  2007-07-05       Impact factor: 49.962

Review 8.  GDNF delivery for Parkinson's disease.

Authors:  N K Patel; S S Gill
Journal:  Acta Neurochir Suppl       Date:  2007

9.  Polymer-encapsulated Schwannoma cells expressing human nerve growth factor promote the survival of cholinergic neurons after a fimbria-fornix transection.

Authors:  M Schinstine; D M Fiore; S R Winn; D F Emerich
Journal:  Cell Transplant       Date:  1995 Jan-Feb       Impact factor: 4.139

10.  Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degeneration.

Authors:  W R Galpern; D M Frim; S B Tatter; C A Altar; M F Beal; O Isacson
Journal:  Cell Transplant       Date:  1996 Mar-Apr       Impact factor: 4.139

View more
  9 in total

Review 1.  Current therapeutic targets for the treatment of Alzheimer's disease.

Authors:  Joshua D Grill; Jeffrey L Cummings
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

Review 2.  Neurotrophic natural products: chemistry and biology.

Authors:  Jing Xu; Michelle H Lacoske; Emmanuel A Theodorakis
Journal:  Angew Chem Int Ed Engl       Date:  2013-12-18       Impact factor: 15.336

3.  Impaired TrkB-mediated ERK1/2 activation in huntington disease knock-in striatal cells involves reduced p52/p46 Shc expression.

Authors:  Silvia Ginés; Paola Paoletti; Jordi Alberch
Journal:  J Biol Chem       Date:  2010-05-04       Impact factor: 5.157

4.  Regulatory Effects of Neuroinflammatory Responses Through Brain-Derived Neurotrophic Factor Signaling in Microglial Cells.

Authors:  Sheng-Wei Lai; Jia-Hong Chen; Hsiao-Yun Lin; Yu-Shu Liu; Cheng-Fang Tsai; Pei-Chun Chang; Dah-Yuu Lu; Chingju Lin
Journal:  Mol Neurobiol       Date:  2018-02-09       Impact factor: 5.590

Review 5.  Depression and risk of developing dementia.

Authors:  Amy L Byers; Kristine Yaffe
Journal:  Nat Rev Neurol       Date:  2011-05-03       Impact factor: 42.937

Review 6.  Cerebrolysin: a review of its use in dementia.

Authors:  Greg L Plosker; Serge Gauthier
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

7.  The Contribution of Microglia to the Development and Maturation of the Visual System.

Authors:  Michael A Dixon; Ursula Greferath; Erica L Fletcher; Andrew I Jobling
Journal:  Front Cell Neurosci       Date:  2021-04-23       Impact factor: 5.505

8.  From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF).

Authors:  Claire Géral; Angelina Angelova; Sylviane Lesieur
Journal:  Pharmaceutics       Date:  2013-02-08       Impact factor: 6.321

9.  Polyoxygenated cyathane diterpenoids from the mushroom Cyathus africanus, and their neurotrophic and anti-neuroinflammatory activities.

Authors:  Jing Wei; Wan-Hui Guo; Chen-Yu Cao; Rong-Wei Kou; Yuan-Zhen Xu; Marcin Górecki; Lorenzo Di Bari; Gennaro Pescitelli; Jin-Ming Gao
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.